UpHealth (NYSE: UPH)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | ||||||
REV | 34.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of UpHealth (NYSE: UPH) through any online brokerage.
Other companies in UpHealth’s space includes: OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR), Better Therapeutics (NASDAQ:BTTX), CareCloud (NASDAQ:MTBC) and Health Catalyst (NASDAQ:HCAT).
The latest price target for UpHealth (NYSE: UPH) was reported by Benchmark on Friday, May 13, 2022. The analyst firm set a price target for 4.00 expecting UPH to rise to within 12 months (a possible 428.54% upside). 5 analyst firms have reported ratings in the last year.
The stock price for UpHealth (NYSE: UPH) is $0.7568 last updated Today at May 23, 2022, 7:59 PM UTC.
There are no upcoming dividends for UpHealth.
UpHealth’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for UpHealth.
UpHealth is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.